Metastatic Lung Cancer

When referring to individuals with cancer, emphasizing the person rather than the condition improves patient morale and refocuses clinicians on the mission of patient-centered care, according to an opinion paper published in JAMA Oncology.

Tiragolumab plus atezolizumab added to chemotherapy did not extend survival outcomes as first-line therapy of locally advanced unresectable or metastatic non-squamous non-small cell lung cancer, interim results from a randomized study showed.

As a 10-year-old in Nashville, Tennessee, Ashley C. Woods, MD, watched her grandmother avoid medical treatment for metastatic lung cancer until it was too late.

A randomized phase 3 study designed to assess sacituzumab govitecan-hziy for treatment of previously treated metastatic non-small cell lung cancer failed to meet its primary endpoint of OS, according to the agent’s manufacturer.

A novel liquid biopsy test can help determine whether patients with oligometastatic non-small cell lung cancer will benefit more from targeted, high-dose radiation instead of drug-based therapy, according to study results.

Healio spoke with Charu Aggarwal, MD, MPH, about findings from her poster presentation on the impact on duration of immunotherapy on OS in metastatic non-small cell lung cancer presented at this year’s ASCO Annual Meeting.

The FDA granted regular approval to selpercatinib for treatment of certain patients with non-small cell lung cancer.

The FDA approved capmatinib for treatment of certain adults with metastatic non-small cell lung cancer.

CHICAGO — Among previously untreated patients with metastatic non-small cell lung cancer, nivolumab plus ipilimumab provided durable, long-term clinical benefit at 5-year follow-up compared with chemotherapy.

First-line treatment with durvalumab plus tremelimumab and chemotherapy appeared effective for patients with metastatic non-small cell lung cancer, according to randomized phase 3 study results.